FDA Seeks Public Feedback on Regulatory Approach for Generative AI -Enabled Medical Devices
It addresses risk assessment, premarket evaluation, postmarket monitoring, and considerations specific to foundation models and agentic AI systems.
Read the original at JDSupra ↗
- Topics
- Regulation & PolicyHealthcareChatbots & LLMsMarkets & InvestmentAI Agents & Automation
- Mentions
- FDA
- Tracked via
- “AI Risks”